Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Adamson

Showing results (11-20 of 415) with videos related to

Pageof 42
Sort By:
Pediatric Blood & Cancer|February 4, 2006
Stress lysis in childhood leukemiaPeter C Adamson
Pediatric Blood & Cancer|November 13, 2009
It's not easy being smallPeter C Adamson
Leukemia|January 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
The Hastings Center Report|October 19, 2007
Case study. All for one, or one for all? CommentaryPeter C Adamson
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Current challenges in pediatric drug developmentPeter C Adamson
JAMA Pediatrics|August 14, 2013
Unintended consequences of regulatory initiatives in childhood cancer drug developmentPeter C Adamson
The Oncologist|January 17, 2020
Early Phase Pediatric Cancer Trials: Progress Highlights ChallengesPeter C Adamson
Delaware State Medical Journal|March 19, 2010
Group psychotherapy; an aid to diagnosis and treatmentW C ADAMSON
JAMA Pediatrics|June 3, 2014
Too few medicines for children with cancer--replyPeter C Adamson
Leukemia|November 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Pageof 42

Showing results (11-20 of 415) with videos related to

Sort By:
Pageof 42
Pediatric Blood & Cancer|February 4, 2006
Stress lysis in childhood leukemiaPeter C Adamson
Pediatric Blood & Cancer|November 13, 2009
It's not easy being smallPeter C Adamson
Leukemia|January 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
The Hastings Center Report|October 19, 2007
Case study. All for one, or one for all? CommentaryPeter C Adamson
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Current challenges in pediatric drug developmentPeter C Adamson
JAMA Pediatrics|August 14, 2013
Unintended consequences of regulatory initiatives in childhood cancer drug developmentPeter C Adamson
The Oncologist|January 17, 2020
Early Phase Pediatric Cancer Trials: Progress Highlights ChallengesPeter C Adamson
Delaware State Medical Journal|March 19, 2010
Group psychotherapy; an aid to diagnosis and treatmentW C ADAMSON
JAMA Pediatrics|June 3, 2014
Too few medicines for children with cancer--replyPeter C Adamson
Leukemia|November 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Pageof 42